2022
DOI: 10.1016/j.ijid.2021.10.035
|View full text |Cite
|
Sign up to set email alerts
|

Performance of four commercial real-time PCR assays for the detection of bacterial enteric pathogens in clinical samples

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 38 publications
(57 reference statements)
1
8
0
Order By: Relevance
“…A poor performance of Y. enterocolitica detection and lack of non- Y. enterocolitica detection was demonstrated by assessing four commercially available real-time PCR systems, including the BD MAX™ system ( 30 ). The poor agreement observed in the study of the four PCR systems for detection of Y. enterocolitica might be explained by known heterogeneity between strains and different choices of chromosomal target genes such as ail , for detection of pathogenic Y. enterocolitica , and yst B, which is also present in most BT1A strains ( 31 , 32 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A poor performance of Y. enterocolitica detection and lack of non- Y. enterocolitica detection was demonstrated by assessing four commercially available real-time PCR systems, including the BD MAX™ system ( 30 ). The poor agreement observed in the study of the four PCR systems for detection of Y. enterocolitica might be explained by known heterogeneity between strains and different choices of chromosomal target genes such as ail , for detection of pathogenic Y. enterocolitica , and yst B, which is also present in most BT1A strains ( 31 , 32 ).…”
Section: Discussionmentioning
confidence: 99%
“…A poor performance of Y. enterocolitica detection and lack of non-Y. enterocolitica detection was demonstrated by assessing four commercially available real-time PCR systems, including the BD MAX TM system (30). The poor agreement observed in the study Analysis of sequence data of Y. enterocolitica O:3/BT4 from sample C2 derived from Ion Torrent and Illumina showed that virulence factors involved in the pathogenicity of Y. enterocolitica, YadA, VirF, and the Yops, carried on a plasmid, were present in the first sequencing data from Ion Torrent and absent in the later sequencing performed using the Illumina platform.…”
Section: Discussionmentioning
confidence: 99%
“…Not all on-site applications reported provide the required low detection limit as demonstrated by our method since reducing the complexity of the method can compromise the detection sensitivity. Additionally, several commercial methods currently exist for the detection of STEC, ranging from nucleic acid-based techniques to immunoassays [37][38][39]. Our described strategy is similarly able to detect both toxins in a manner that is specific.…”
Section: Discussionmentioning
confidence: 99%
“…The stx2f subtype is the most divergent (by nucleotide and amino acid sequence) of the known Stx2 subtypes [30], showing very low homology with other subtypes. Assay evaluation studies have shown that certain in-house and commercial PCR assays, and immunoassays targeting gastrointestinal pathogens including STEC, do not detect stx2f [29,[31][32][33][34], leading to under reporting of this variant. Given the uncertainty as to whether E. coli encoding stx2f can cause severe clinical outcomes and the limitations of the current diagnostic assays, we aimed to analyse the laboratory data linked to isolates of stx2f-positive E. coli in the UKHSA archive, review the clinical outcome data and assess the public health burden of strains of Stx2f-producing E. coli in England.…”
Section: Introductionmentioning
confidence: 99%